Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Clin Lung Cancer. 2016 Aug 20;18(2):189–197.e3. doi: 10.1016/j.cllc.2016.07.008

Figure 2.

Figure 2

Figure 2a and 2b. Unadjusted (2a) and Propensity Score Matched (2b) Kaplan-Meier Survival Curves for Patients with Non-Squamous, Non-Small-Cell Lung Cancer Receiving Carboplatin and Paclitaxel (CP) with or without and Concomitant Receipt of Angiotensin-System Inhibitors (ASIS) with rr without Concomitant Receipt of Angiotensin-System Inhibitors (ASIS)